IMIDAZOCHINOLINE MIT IMMUNMODULIERENDEN EIGENSCHAFTEN

Patent europeic · EP2155743 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2155743
Numer da la dumonda
EP08737252
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
06-05-2008
Publitgà
24-02-2010
Concedì
29-08-2012
Stritgà
31-05-2019
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 471/04 (2006.01)
A61K 31/437 (2006.01)
A61P 37/02 (2006.01)
Prioritad
US 916586 P 08.05.2007
US 24957 P 31.01.2008
Dumonda PCT
PCT/GB2008/050328 06.05.2008
Publicaziun PCT
WO2008/135791 13.11.2008
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 18-12-2019

    Stritgà, taxa betg pajada

    Published in Swissreg on 18.12.2019

  2. 09-11-2016

    Transferì

    Owner
    AstraZeneca AB, 151 85 Södertälje, Sweden, Dainippon Sumitomo Pharma Co., Ltd., 6-8, Dosho-machi 2-chome, Chuo-ku, Osaka-shi, Osaka, Japan → SUMITOMO DAINIPPON PHARMA CO., LTD., 6-8, Dosho-machi 2-chome, Chuo-ku, Osaka-shi, Osaka, Japan

    Published in Swissreg on 09.11.2016

  3. 29-08-2012

    Concedì

    Published in Swissreg on 29.08.2012

Partidas

Inventur

BONNERT, Roger, Victor

Loughborough Leicestershire LE11 5RH, GB

MCINALLY, Thomas

Loughborough Leicestershire LE11 5RH, GB

THOM, Stephen

Loughborough Leicestershire LE11 5RH, GB

WADA, Hiroki

Loughborough, Leicestershire LE11 5RH, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.